Hansoh Pharmaceutical Group Company Limited - Laporan Laba Rugi (TTM)

Hansoh Pharmaceutical Group Company Limited
US ˙ OTCPK ˙ KYG549581067

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Hansoh Pharmaceutical Group Company Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 8,377 8,690 8,901 9,112 9,524 9,935 9,952 9,968 9,675 9,382 9,421 9,459 9,782 10,104 11,101 12,098 12,179 12,261 12,725 13,189
Change (%) 3.74 2.43 2.37 4.52 4.32 0.17 0.17 -2.94 -3.03 0.41 0.41 3.41 3.29 9.87 8.98 0.67 0.67 3.78 3.65
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 762 803 829 856 863 870 862 853 862 870 936 1,002 1,017 1,033 1,060 1,087 1,102 1,117 1,162 1,208
Change (%) 5.48 3.24 3.14 0.87 0.86 -1.01 -1.02 1.02 1.01 7.60 7.06 1.50 1.48 2.65 2.59 1.35 1.33 4.10 3.94
% of Revenue 9.09 9.24 9.32 9.39 9.06 8.76 8.66 8.56 8.90 9.27 9.94 10.60 10.40 10.22 9.55 8.99 9.05 9.11 9.14 9.16
Gross Operating Profit 7,615 7,887 8,072 8,257 8,661 9,065 9,090 9,115 8,814 8,512 8,484 8,457 8,764 9,071 10,041 11,011 11,077 11,144 11,562 11,981
Change (%) 3.57 2.34 2.29 4.89 4.67 0.28 0.28 -3.31 -3.42 -0.33 -0.33 3.63 3.51 10.69 9.66 0.61 0.60 3.75 3.62
% of Revenue 90.91 90.76 90.68 90.61 90.94 91.24 91.34 91.44 91.10 90.73 90.06 89.40 89.60 89.78 90.45 91.01 90.95 90.89 90.86 90.84
SG&A 3,751 3,862 3,945 4,027 4,199 4,371 4,378 4,385 4,266 4,148 4,160 4,172 4,207 4,241 4,278 4,316 4,412 4,508 4,551 4,595
Change (%) 2.94 2.15 2.10 4.27 4.09 0.15 0.15 -2.70 -2.78 0.29 0.29 0.83 0.82 0.88 0.88 2.23 2.18 0.96 0.95
% of Revenue 44.78 44.44 44.31 44.20 44.09 44.00 43.99 43.99 44.09 44.21 44.16 44.11 43.00 41.97 38.54 35.67 36.23 36.77 35.77 34.84
R&D 1,146 1,252 1,358 1,463 1,630 1,797 1,823 1,849 1,771 1,693 1,789 1,884 1,990 2,097 2,231 2,364 2,533 2,702 2,824 2,946
Change (%) 9.30 8.41 7.76 11.42 10.25 1.45 1.43 -4.21 -4.40 5.62 5.32 5.66 5.36 6.37 5.98 7.14 6.67 4.52 4.33
% of Revenue 13.68 14.41 15.25 16.05 17.11 18.09 18.32 18.55 18.31 18.05 18.98 19.91 20.35 20.76 20.09 19.54 20.80 22.03 22.19 22.34
OpEx 5,659 5,917 6,109 6,301 6,708 7,115 7,207 7,299 7,037 6,775 6,911 7,046 7,235 7,424 7,641 7,857 8,108 8,359 8,544 8,730
Change (%) 4.57 3.24 3.14 6.45 6.06 1.30 1.28 -3.59 -3.72 2.00 1.96 2.68 2.61 2.91 2.83 3.19 3.09 2.22 2.17
% of Revenue 67.55 68.09 68.63 69.15 70.43 71.61 72.42 73.22 72.73 72.21 73.35 74.49 73.97 73.48 68.83 64.94 66.57 68.17 67.15 66.19
Operating Income 2,718 2,773 2,792 2,811 2,816 2,821 2,745 2,669 2,638 2,607 2,510 2,413 2,546 2,679 3,460 4,241 4,072 3,902 4,180 4,459
Change (%) 2.03 0.69 0.68 0.17 0.17 -2.68 -2.76 -1.16 -1.17 -3.73 -3.87 5.52 5.23 29.14 22.57 -4.00 -4.16 7.13 6.66
% of Revenue 32.45 31.91 31.37 30.85 29.57 28.39 27.58 26.78 27.27 27.79 26.65 25.51 26.03 26.52 31.17 35.06 33.43 31.83 32.85 33.81
Interest Expense -1 -2 -15 -28 -41 -53 -54 -54 -56 -58 -59 -60 -63 -67 -54 -41 -24 -7 -5 -3
Change (%) 51.13 810.49 89.02 43.29 30.21 1.46 1.44 3.48 3.36 1.79 1.76 5.36 5.09 -19.34 -23.98 -41.82 -71.88 -24.74 -32.88
% of Revenue -0.01 -0.02 -0.17 -0.31 -0.43 -0.53 -0.54 -0.55 -0.58 -0.62 -0.63 -0.64 -0.65 -0.66 -0.48 -0.34 -0.20 -0.05 -0.04 -0.03
Net Income 2,526 2,569 2,603 2,638 2,675 2,713 2,717 2,720 2,652 2,584 2,579 2,575 2,926 3,278 3,996 4,714 4,543 4,372 4,577 4,781
Change (%) 1.71 1.34 1.32 1.43 1.41 0.14 0.14 -2.51 -2.57 -0.18 -0.18 13.65 12.01 21.92 17.98 -3.63 -3.77 4.68 4.47
% of Revenue 30.15 29.56 29.25 28.95 28.09 27.31 27.30 27.29 27.41 27.54 27.38 27.22 29.91 32.44 36.00 38.97 37.30 35.66 35.97 36.25

Source: Capital IQ

Other Listings
DE:3KY € 3.86
HK:3692 HK$ 37.12
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista